Senate Bill 2329
118th Congress(2023-2024)
Emerging Pathogen Preparedness Program Authorization Act
Introduced
Introduced in Senate on Jul 13, 2023
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2329
Congress
118
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Emerging Pathogen Preparedness Program Authorization Act
This bill establishes a program in the Food and Drug Administration's Center for Biologics Evaluation and Research to support the development and approval of biological countermeasures. Authorized activities include the development of quality measures for countermeasures, surveillance programs to monitor countermeasures, and research and development of platform vaccine technology to support emergency use authorization requests.
July 13, 2023
Sort by most recent
07/13/2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
07/13/2023
Introduced in Senate
Public Record
Record Updated
Oct 4, 2024 8:11:29 PM